Affordable Access

Benefices multiples de la corticotherapie antenatale. Etat de la question en communaute Francaise de Belgique

Publication Date
  • Human Health Sciences :: Reproductive Medicine (Gynecology
  • Andrology
  • Obstetrics) [D24]
  • Sciences De La Santé Humaine :: Médecine De La Reproduction (Gynécologie
  • Andrologie
  • Obstétrique) [D24]
  • Biology
  • Medicine


The benefit of antenatal administration of corticosteroids (betamethasone or dexamethasone) in the newborn prematured babies before the 34 week of gestation has been well demonstrated: reduction of respiratory distress syndrome but also a decrease in the incidence of severe intraventricular hemorrhages, episodes of necrotising enterocolitis and neonatal mortality. In this article, we report the impact of this treatment in the Belgian French Community in the population of infants with a birth weight below 1,500 g, born between 1990 and 1994 in the seven neonatal intensive care units. Based on this epidemiological study (compared with international publications) we propose the routine use of corticosteroids during the antenatal period, with the aim of seeing an increase in the use of this treatment, which, although costing little, produces clinical benefit.

There are no comments yet on this publication. Be the first to share your thoughts.